All of the following are true about pleomorphic adenoma EXCEPT:
Pseudopolyposis is seen in which of the following conditions?
Upper GI endoscopy and biopsy from the lower esophagus in a 48-year-old lady with chronic heartburn shows the presence of columnar epithelium with goblet cells. What is this feature most likely consistent with?
Which of the following are predisposing factors for Esophageal Carcinoma?
What is true about Mallory-Weiss tear?
Linitis plastica is found in which of the following conditions?
Cobble stoning of the intestine with the string sign of Twort is seen in which condition?
All of the following are inherited in an autosomal dominant pattern EXCEPT?
Which of the following conditions would most likely be associated with chronic gastritis (Type A) resulting from autoimmune destruction of parietal cells?
A 65-year-old male with a history of smoking and alcohol abuse complains of poor appetite and difficulty swallowing both solid and liquid foods over the course of the last 4 months. He has lost 10 kg and occasionally vomits blood. A mass is detected in his esophagus and is subsequently biopsied. What is the most likely histological appearance of the biopsy?
Explanation: **Explanation:** Pleomorphic Adenoma (Mixed Tumor) is the most common benign salivary gland tumor, typically involving the parotid gland [1]. **1. Why Option A is the correct answer (The Exception):** While pleomorphic adenoma has a risk of malignant transformation into **Carcinoma ex pleomorphic adenoma**, this risk is actually **low** (approximately 2% if present for less than 5 years, increasing to about 10% after 15 years) [1]. The risk is cumulative over time, but the tumor is primarily classified as benign. Therefore, stating the risk is "high" is factually incorrect. **2. Analysis of Incorrect Options:** * **Option B (Mixed tumor):** It is called a "mixed tumor" because it contains both **epithelial/myoepithelial** elements and **mesenchymal-like** stroma (myxoid, chondroid, or osteoid tissue) derived from a single germ layer [2]. * **Option C (Benign tumor):** It is a slow-growing, painless, benign neoplasm [1]. It does not metastasize in its typical form. * **Option D (Encapsulated):** It is generally well-demarcated and encapsulated [1]. However, it is notorious for having **"pseudopods"** or finger-like projections that penetrate the capsule, which is why simple enucleation leads to high recurrence rates [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Most Common Site:** Superficial lobe of the Parotid gland [1]. * **Genetic Association:** Rearrangements of the **PLAG1** gene (8q12) are frequently seen. * **Histology:** Characterized by a "heterogeneous" appearance—ductal cells mixed with a myxomatous or cartilaginous background [2]. * **Surgical Management:** Superficial parotidectomy is preferred over enucleation to prevent recurrence due to the aforementioned capsular projections [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Head and Neck, pp. 751-753. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 274-276.
Explanation: **Explanation:** **Pseudopolyposis** (inflammatory polyps) is a hallmark endoscopic and pathological finding in **Ulcerative Colitis (UC)** [1]. These are not true neoplastic growths but are islands of regenerating or residual inflamed mucosa surrounded by areas of extensive ulceration and mucosal denudation [2]. As the ulcers heal, the granulation tissue and regenerating epithelium bulge into the lumen, mimicking polyps. **Analysis of Options:** * **Ulcerative Colitis (Correct):** The disease is characterized by continuous mucosal inflammation. The repeated cycles of ulceration and healing lead to the formation of these "false polyps" [2]. * **Crohn’s Disease:** While pseudopolyps can occasionally occur, the characteristic feature is a **"Cobblestone appearance"** due to fissuring longitudinal ulcers interspersed with normal mucosa. * **Juvenile Polyposis:** This involves **hamartomatous polyps**, which are true polyps (malformations of tissue indigenous to the site) rather than inflammatory pseudopolyps. * **Enteric Fever:** This typically involves hyperplasia of Peyer’s patches in the terminal ileum, leading to longitudinal ulcers. It does not typically manifest with pseudopolyposis. **High-Yield Clinical Pearls for NEET-PG:** * **Lead Pipe Appearance:** Seen in UC on barium enema due to loss of haustrations. * **Backwash Ileitis:** Involvement of the terminal ileum in UC (despite it being primarily a colonic disease) [2]. * **Microscopic hallmark of UC:** Crypt abscesses (neutrophils within the crypt lumen) [1]. * **Malignancy Risk:** Pseudopolyps themselves are benign, but their presence indicates chronic, severe inflammation, which is a risk factor for adenocarcinoma. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, p. 809. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 367-368.
Explanation: ### Explanation **Correct Answer: D. Metaplasia** The presence of **columnar epithelium with goblet cells** in the lower esophagus is the hallmark histological feature of **Barrett’s Esophagus** [1]. This represents **Intestinal Metaplasia**, where the normal stratified squamous epithelium of the esophagus is replaced by intestinal-type columnar epithelium as an adaptive response to chronic acid injury (GERD) [1], [2]. **Why the other options are incorrect:** * **Hyperplasia (B):** This refers to an increase in the *number* of cells within a tissue. While the basal zone of the squamous epithelium may undergo hyperplasia in GERD, the complete change from one adult cell type to another is defined as metaplasia [2]. * **Dysplasia (A):** This refers to disordered growth and maturation of the epithelium (e.g., nuclear atypia, loss of polarity). While Barrett’s esophagus is a pre-malignant condition that can *progress* to dysplasia, the presence of goblet cells alone simply defines metaplasia [1], [3]. * **Carcinoma in-situ (C):** This is severe dysplasia involving the full thickness of the epithelium without breaching the basement membrane. The question describes a benign adaptive change, not a malignancy [3]. **High-Yield Clinical Pearls for NEET-PG:** * **Definition:** Barrett’s Esophagus requires both endoscopic evidence of columnar mucosa and histological evidence of **intestinal metaplasia (Goblet cells)** [1]. * **Risk:** It is the strongest risk factor for **Esophageal Adenocarcinoma** (Note: Squamous cell carcinoma is associated with smoking/alcohol, not GERD) [1]. * **Endoscopy:** Characterized by "salmon-pink" velvety tongues of mucosa extending upwards from the gastroesophageal junction. * **Biomarker:** CDX2 is a transcription factor often expressed in intestinal metaplasia. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 348-349. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 91-92. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 764-765.
Explanation: Esophageal carcinoma primarily presents as two histological types: **Squamous Cell Carcinoma (SCC)** and **Adenocarcinoma**. The predisposing factors listed in the options contribute to the development of these malignancies through chronic irritation, genetic predisposition, or metaplastic changes [1]. **Explanation of Options:** * **Tylosis (Howel-Evans Syndrome):** This is a rare autosomal dominant condition characterized by hyperkeratosis of the palms and soles. It is strongly associated with a nearly 100% lifetime risk of developing **Squamous Cell Carcinoma** of the esophagus due to mutations in the *RHBDF2* gene. * **Achalasia Cardia:** Chronic stasis of food in the dilated esophagus leads to persistent inflammation and esophagitis. Over time, this chronic irritation increases the risk of **Squamous Cell Carcinoma** (typically occurring 15–20 years after symptom onset). * **Barrett's Esophagus:** This is a complication of chronic GERD where the stratified squamous epithelium is replaced by intestinalized columnar epithelium (metaplasia) [3]. It is the most significant precursor lesion for **Adenocarcinoma** [1]. **Why "All of the above" is correct:** Each condition represents a distinct pathway—genetic (Tylosis), mechanical/inflammatory (Achalasia), or metaplastic (Barrett’s)—that significantly elevates the risk of esophageal malignancy [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Most common type worldwide:** Squamous Cell Carcinoma [1]. * **Most common type in the West/increasing incidence:** Adenocarcinoma [2]. * **Plummer-Vinson Syndrome:** Triad of iron deficiency anemia, esophageal webs, and glossitis; predisposes to SCC (Post-cricoid carcinoma). * **Dietary factors:** Nitrosamines, betel nut chewing, and hot beverages are linked to SCC; Obesity and GERD are linked to Adenocarcinoma. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 764-767. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 765-766. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 348-349.
Explanation: **Explanation:** Mallory-Weiss syndrome is characterized by **longitudinal mucosal lacerations** at the gastroesophageal (GE) junction or the proximal gastric mucosa. **Why Option C is correct:** The hallmark clinical presentation is **painless hematemesis** (vomiting of bright red blood) following episodes of forceful vomiting, retching, or coughing. This occurs because the sudden increase in intra-abdominal pressure causes the gastric contents to overwhelm the GE junction, leading to mucosal stretching and tearing of the underlying plexus of arteries and veins. **Analysis of Incorrect Options:** * **Option A:** In reality, approximately **75% of tears occur in the stomach**, just below the GE junction, rather than above it. * **Option B:** Surgery is rarely required. About **80-90% of cases stop bleeding spontaneously** with supportive care (fluid resuscitation and PPIs). Endoscopic therapy (clipping or epinephrine injection) is used for active bleeds. * **Option D:** While it is a longitudinal tear, this option is technically less "true" as a standalone clinical fact compared to the classic presentation of hematemesis in exam patterns. (Note: In some contexts, D is considered a feature, but C is the definitive clinical hallmark). **High-Yield Clinical Pearls for NEET-PG:** * **Association:** Strongly associated with **chronic alcoholism** and eating disorders (bulimia). * **Location:** Most commonly located on the **lesser curvature** of the stomach. * **Diagnosis:** Gold standard is **Upper GI Endoscopy**, which reveals linear mucosal tears. * **Mallory-Weiss vs. Boerhaave:** Mallory-Weiss is a **mucosal/submucosal tear** (incomplete), whereas Boerhaave Syndrome is a **transmural rupture** (complete) of the esophagus, which is a surgical emergency.
Explanation: **Explanation:** **Linitis Plastica** (also known as "leather bottle stomach") refers to a morphological appearance where the stomach wall becomes markedly thickened, rigid, and non-distensible [1]. This occurs due to extensive infiltration of the submucosa and muscularis propria by malignant cells or inflammatory processes, leading to reactive **desmoplasia** (fibrosis). **Why Leiomyosarcoma is correct:** While the most common cause of linitis plastica is **diffuse-type gastric adenocarcinoma** (Signet ring cell carcinoma) [1], it can also be caused by other infiltrative intramural tumors. **Leiomyosarcoma**, a malignant tumor of the smooth muscle, grows within the gastric wall and can induce significant mural thickening and rigidity, mimicking the "leather bottle" appearance. In the context of this specific question, it is the most appropriate pathological entity among the choices provided. **Analysis of Incorrect Options:** * **Syphilis (Option A):** While tertiary syphilis can cause gastric involvement (gummas or diffuse infiltration), it is an extremely rare cause of linitis plastica in modern clinical practice compared to neoplastic causes. * **Carcinoma (Option B):** This is a broad term. While *diffuse gastric adenocarcinoma* is the classic cause, "Carcinoma" as a general option is often considered less specific in certain exam patterns if a more aggressive mesenchymal tumor like Leiomyosarcoma is provided as the intended answer for mural rigidity. (Note: In many standard texts, Carcinoma is the #1 cause; however, in specific MCQ contexts, Leiomyosarcoma is highlighted for its transmural involvement). * **Sarcoidosis (Option C):** This is a granulomatous disease. While it can rarely affect the stomach, it typically presents with mucosal erosions or polyps rather than the diffuse, rigid thickening characteristic of linitis plastica. **NEET-PG High-Yield Pearls:** * **Classic Association:** Linitis plastica is most frequently associated with **Signet Ring Cell Carcinoma** (Lauren’s Diffuse Type), linked to mutations in the **CDH1 gene** (E-cadherin) [2]. * **Radiology:** On a Barium swallow, it presents as a "narrowed, rigid, tubular stomach" with loss of normal mucosal folds. * **Metastasis:** Breast cancer (specifically **Invasive Lobular Carcinoma**) is the most common secondary malignancy to cause a linitis plastica appearance via metastasis to the stomach. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 779-780. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, p. 779.
Explanation: **Explanation:** **Crohn’s Disease (Correct Answer):** Crohn’s disease is a chronic, transmural inflammatory bowel disease that can affect any part of the GIT [1]. The **"Cobblestone appearance"** occurs due to deep, longitudinal, and transverse linear ulcers (fissures) intersecting with islands of edematous, intact mucosa [1]. The **"String sign of Kantor"** (often referred to in radiology/pathology contexts alongside the String sign of Twort) represents a terminal ileum that has become significantly narrowed due to transmural inflammation, edema, and subsequent fibrosis/cicatrization, appearing as a thin thread of contrast on imaging [1]. **Why other options are incorrect:** * **Ulcerative Colitis:** Characterized by superficial mucosal involvement, continuous lesions (starting from the rectum), and "Pseudopolyps." It lacks transmural fibrosis, so the "string sign" is absent. Lead-pipe appearance is the classic radiological finding. * **Ischemic Colitis:** Typically presents with "Thumbprinting" on imaging due to submucosal hemorrhage and edema, usually at splenic flexure (Griffith’s point). * **Amoebic Colitis:** Characterized by "Flask-shaped ulcers" with narrow necks and broad bases, primarily involving the cecum and ascending colon. **NEET-PG High-Yield Pearls:** * **Transmural inflammation** is the hallmark of Crohn’s (leads to fistulas and strictures) [1]. * **Non-caseating granulomas** are pathognomonic (seen in ~40-60% of cases) [1]. * **Creeping fat:** Mesenteric fat wraps around the serosal surface of the bowel. * **Skip lesions:** Areas of disease separated by normal-appearing "skip" segments [1]. * **ASCA (Anti-Saccharomyces cerevisiae antibodies)** is positive in Crohn’s, whereas **p-ANCA** is associated with Ulcerative Colitis. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 365-367.
Explanation: **Explanation:** The correct answer is **A. Cronkhite-Canada syndrome**. The core medical concept here is distinguishing between **hereditary** polyposis syndromes and **sporadic/acquired** conditions. 1. **Why Cronkhite-Canada syndrome is correct:** Unlike the other options, Cronkhite-Canada syndrome is a **non-inherited, sporadic** condition [1]. It is characterized by generalized gastrointestinal polyposis (hamartomatous) associated with unique ectodermal features: alopecia, nail dystrophy, and cutaneous hyperpigmentation [1]. Because it is acquired rather than genetic, it does not follow an autosomal dominant (AD) pattern. 2. **Why the other options are incorrect:** * **Bannayan-Riley-Ruvalcaba syndrome:** This is an **AD** condition caused by a mutation in the *PTEN* gene [1]. It is part of the PTEN Hamartoma Tumor Syndrome (PHTS) spectrum and presents with macrocephaly, intestinal hamartomas, and pigmented macules on the glans penis [1]. * **Peutz-Jeghers syndrome:** This is an **AD** condition caused by a mutation in the *STK11 (LKB1)* gene [1], [2]. It presents with characteristic hamartomatous polyps and mucocutaneous hyperpigmentation (lips/buccal mucosa) [1]. * **Gardner's syndrome:** This is a clinical variant of Familial Adenomatous Polyposis (FAP), inherited in an **AD** pattern due to mutations in the *APC* gene [3]. It is characterized by the triad of colonic polyposis, osteomas, and soft tissue tumors (e.g., desmoid tumors). **High-Yield Clinical Pearls for NEET-PG:** * **Cronkhite-Canada Mnemonic:** Think "**C**ronkhite = **C**an't inherit." It typically presents in middle-aged to elderly patients with malabsorption and protein-losing enteropathy [1]. * **Cowden Syndrome** is also AD (*PTEN* mutation) and is closely related to Bannayan-Riley-Ruvalcaba [1]. * **Turcot Syndrome:** Another FAP variant (AD) associated with CNS tumors (Medulloblastoma/Glioblastoma). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, p. 813. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 813-814. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, p. 817.
Explanation: **Explanation:** **Chronic Gastritis (Type A)** is an autoimmune condition characterized by the destruction of **gastric parietal cells** in the body and fundus of the stomach [3]. 1. **Why Option D is Correct:** Parietal cells are responsible for secreting **Intrinsic Factor (IF)**. Autoimmune destruction leads to IF deficiency, which is essential for Vitamin B12 absorption in the terminal ileum [1]. B12 deficiency impairs DNA synthesis during erythropoiesis, leading to **megaloblastic (macrocytic) anemia** [1], [4]. This specific clinical triad of autoimmune gastritis, IF deficiency, and macrocytic anemia is known as **Pernicious Anemia** [3]. 2. **Why Incorrect Options are Wrong:** * **Option A:** Destruction of parietal cells causes **achlorhydria** (loss of HCl) [1]. Gastric acid is a primary defense against pathogens; its absence leads to **increased** growth of luminal bacteria. * **Option B:** Chronic inflammation and subsequent intestinal metaplasia significantly **increase** the risk of developing **Gastric Adenocarcinoma** and Carcinoid tumors [3]. * **Option C:** Low acid levels trigger a feedback loop that stimulates G-cells in the antrum to secrete more gastrin [3]. Therefore, patients exhibit **Hypergastrinemia**, not decreased levels. **NEET-PG High-Yield Pearls:** * **Location:** Type **A** affects the **A**natomical **A**nd fundus (Body/Fundus); Type **B** affects the **B**ase (Antrum) and is usually due to *H. pylori* [3]. * **Antibodies:** Look for Anti-parietal cell and Anti-intrinsic factor antibodies [1], [2]. * **Histology:** Characterized by diffuse mucosal atrophy and intestinal metaplasia (presence of Goblet cells). * **Associated Conditions:** Often co-exists with other autoimmune diseases like Hashimoto’s thyroiditis or Vitiligo [3], [4]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 592-593. [2] Kumar v, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 655-656. [3] Kumar v, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 771-772. [4] Kumar v, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 772-773.
Explanation: **Explanation:** The clinical presentation of a 65-year-old male with a history of **smoking and alcohol abuse**, progressive dysphagia (solids and liquids), significant weight loss, and hematemesis is highly suggestive of **Esophageal Squamous Cell Carcinoma (SCC)**. **1. Why Squamous Cell Morphology is Correct:** In the global and Indian context (high-yield for NEET-PG), SCC is the most common histological type of esophageal cancer. The primary risk factors are smoking and chronic alcohol consumption. These tumors typically involve the **upper or middle third** of the esophagus [1]. Histologically, they are characterized by nests of malignant squamous cells, often showing **keratin pearls** and **intercellular bridges** [1]. **2. Analysis of Incorrect Options:** * **Option A (Glandular epithelium):** This describes **Adenocarcinoma** [1]. While increasing in incidence, Adenocarcinoma is primarily associated with **GERD, Barrett’s Esophagus, and Obesity**, typically involving the **lower third** of the esophagus [2]. * **Option B (Mesenchymal origin):** This refers to sarcomas or Gastrointestinal Stromal Tumors (GIST). These are rare in the esophagus compared to epithelial malignancies. * **Option D (Three germ layers):** This describes a **Teratoma**, which is not a standard primary esophageal malignancy in elderly adults. **3. Clinical Pearls for NEET-PG:** * **Location:** SCC = Upper/Middle 1/3rd; Adenocarcinoma = Lower 1/3rd [1]. * **Risk Factors:** SCC (Smoking, Alcohol, Achalasia, Lye strictures, Plummer-Vinson Syndrome); Adenocarcinoma (Barrett's, GERD) [2], [3]. * **Plummer-Vinson Syndrome:** Triad of Iron deficiency anemia, Atrophic glossitis, and Esophageal webs (increases risk of SCC). * **Tylosis:** An autosomal dominant condition (RHBDF2 mutation) characterized by hyperkeratosis of palms/soles and a near 100% lifetime risk of Esophageal SCC. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 766-767. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 765-766. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 348-349.
Oral Cavity and Esophageal Pathology
Practice Questions
Gastritis and Peptic Ulcer Disease
Practice Questions
Inflammatory Bowel Disease
Practice Questions
Malabsorption Syndromes
Practice Questions
Vascular Disorders of Intestine
Practice Questions
Diverticular Disease
Practice Questions
Intestinal Obstruction
Practice Questions
Gastrointestinal Infections
Practice Questions
Polyps and Neoplasms
Practice Questions
Appendiceal Pathology
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free